INHALABLE PHARMACEUTICAL COMPOSITION FOR PREVENTION OR TREATMENT OF CORONAVIRUS DISEASE 2019 (COVID-19)

The present invention relates to an inhalable pharmaceutical composition comprising budesonide or formoterol for preventing or treating COVID-19, and the composition exhibits more superb inhibitory effects on the virus than remdesivir injections and ciclesonide inhalations, which are known as therap...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: KANG, Won Ho, CHOI, Youn Woong, SHIN, Dong Seok, CHOI, Ji Hoon, YOU, Gweon Hee
Format: Patent
Sprache:eng ; fre ; kor
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The present invention relates to an inhalable pharmaceutical composition comprising budesonide or formoterol for preventing or treating COVID-19, and the composition exhibits more superb inhibitory effects on the virus than remdesivir injections and ciclesonide inhalations, which are known as therapeutic agents for COVID-19. La présente invention concerne une composition pharmaceutique inhalable comprenant du budésonide ou du formotérol pour la prévention ou le traitement de la COVID-19 et la composition présente des effets encore plus excellents sur l'inhibition virale que les injections de remdésivir et les inhalations de ciclésonide, qui sont connus en tant qu'agents thérapeutiques pour la COVID-19. 본 발명은 부데소니드 및 포르모테롤을 포함하는 코로나 19 예방 또는 치료용 흡입형 약학조성물에 관한 것으로 코로나 19 치료제로 알려진 렘데시비르 주사제제 및 시클레소니드 흡입제보다도 바이러스 억제에 더욱 우수한 효과를 나타낸다.